The biggest threat to the scientific community when it comes to innovative and safe applications of mycelia/fungi is Big Pharma. Though Big Pharma is not the topic of this blog, it must be dealt with because of its business practices, for example, requiring years of Prosac instead of two-three capsules of a specific fungus to … Continue reading Thoughts beyond the Novel CoCC.5–Mycelia/Fungi